Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01740219 · ClinicalTrials.gov registry record · NA
Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 348
- Enrollment target
NCT01740219: Completed NA study, sponsored by Dana-Farber Cancer Institute.
NCT01740219 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 348 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01740219, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 348 participants
- Enrollment target
Study Summary
This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos. The investigators partner with faith-based organizations, since they play a highly prominent role in Latino community life. This three-phase study will: (1) improve understanding of the organizational infrastructure, skills and resources required by Latino churches to implement EBIs for cancer control, (2) develop a capacity-building intervention; and (3) test the intervention's effectiveness in a randomized trial.
Primary Outcome
Number and types of interventions offered
Interventions
- BEHAVIORAL Capacity Enhancement
- BEHAVIORAL Standard Dissemination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 348 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT01740219 record still lists
NCT01740219 is an interventional study that assigns participants to a tested intervention. The registered 348 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Capacity Enhancement is the first listed.
NCT01740219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01740219 about?
NCT01740219 is a clinical study titled "Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches". This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos. The investigators partner with faith-based organizations, since they play a highly pr...
What is the current status of trial NCT01740219?
This trial is currently completed. It is a NA study. The enrollment target is 348 participants. The study started on 2011-09. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01740219?
The interventions under investigation include: Capacity Enhancement (BEHAVIORAL), Standard Dissemination (BEHAVIORAL).
Who is sponsoring clinical trial NCT01740219?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01740219's enrollment target sits among peer trials
348 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041479 · 348 participants · Phase 3
Biomarker-guided rTMS for Treatment Resistant Depression
- NCT04530565 · 348 participants · Phase 3
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
- NCT05428735 · 348 participants · NA
The DRAGON 2 Trial
- NCT05787379 · 348 participants · NA
Care for Veterans Post-COVID-19
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia